Cargando…

Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK

BACKGROUND: This paper describes the development of a Cancer Awareness Measure for colorectal (CRC) cancer (Bowel/Colorectal CAM(a)) (study 1) and presents key results from a population-representative survey using the measure (study 2). METHODS: STUDY 1: Items were taken from the literature and revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Power, Emily, Simon, Alice, Juszczyk, Dorota, Hiom, Sara, Wardle, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188511/
https://www.ncbi.nlm.nih.gov/pubmed/21859500
http://dx.doi.org/10.1186/1471-2407-11-366
_version_ 1782213384274444288
author Power, Emily
Simon, Alice
Juszczyk, Dorota
Hiom, Sara
Wardle, Jane
author_facet Power, Emily
Simon, Alice
Juszczyk, Dorota
Hiom, Sara
Wardle, Jane
author_sort Power, Emily
collection PubMed
description BACKGROUND: This paper describes the development of a Cancer Awareness Measure for colorectal (CRC) cancer (Bowel/Colorectal CAM(a)) (study 1) and presents key results from a population-representative survey using the measure (study 2). METHODS: STUDY 1: Items were taken from the literature and reviewed by expert groups. A series of three validation studies assessed reliability and validity of the measure. To establish test-retest reliability, 49 people over 50 years of age completed the Bowel/Colorectal CAM on two occasions (range 9-14 days, mean 13.5 days). Construct validity was assessed by comparing responses from bowel cancer experts (n = 16) and the lay public (n = 35). Lastly, a brief intervention study tested sensitivity to change with participants (n = 70) randomly allocated to be given a control leaflet or an intervention leaflet and their responses were compared. STUDY 2: 1520 respondents completed the Bowel/Colorectal CAM in a population survey carried out by TNS-British Market Research Bureau International (TNS-BMRB) in March 2010. RESULTS: STUDY 1: Internal reliability (Cronbach's alpha = 0.84) was high. Test-retest reliability was over r = 0.7 for warning signs, risk factors and age people are first invited for screening, but lower (between 0.6 and 0.7) for other items (lifetime risk, awareness of bowel cancer screening, age at risk). Bowel cancer experts achieved higher scores than equally educated controls (54.7 [4.3] vs. 42.9 [5.7]; P < 0.001) demonstrating the measure has construct validity and intervention participants showed higher knowledge than controls (51.4 [5.9] vs. 42.9 [5.7]; P < 0.001) suggesting the measure is sensitive to change. STUDY 2: Respondents recalled on average, one CRC sign and one risk factor. There was particularly low prompted awareness of the signs 'lump in the abdomen' (64%) and 'tiredness' (50%) and several lifestyle risk factors for CRC, e.g. exercise (37%). Respondents from more affluent groups had consistently higher knowledge of signs and risk factors compared to those from more deprived groups. CONCLUSIONS: The Bowel/Colorectal CAM meets accepted psychometric criteria for reliability and construct validity and should therefore provide a useful tool for assessment of CRC awareness. The population survey revealed low awareness of several CRC signs and risk factors and emphasises the importance of continuing public education, particularly about the link between lifestyle behaviours and CRC.
format Online
Article
Text
id pubmed-3188511
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31885112011-10-07 Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK Power, Emily Simon, Alice Juszczyk, Dorota Hiom, Sara Wardle, Jane BMC Cancer Research Article BACKGROUND: This paper describes the development of a Cancer Awareness Measure for colorectal (CRC) cancer (Bowel/Colorectal CAM(a)) (study 1) and presents key results from a population-representative survey using the measure (study 2). METHODS: STUDY 1: Items were taken from the literature and reviewed by expert groups. A series of three validation studies assessed reliability and validity of the measure. To establish test-retest reliability, 49 people over 50 years of age completed the Bowel/Colorectal CAM on two occasions (range 9-14 days, mean 13.5 days). Construct validity was assessed by comparing responses from bowel cancer experts (n = 16) and the lay public (n = 35). Lastly, a brief intervention study tested sensitivity to change with participants (n = 70) randomly allocated to be given a control leaflet or an intervention leaflet and their responses were compared. STUDY 2: 1520 respondents completed the Bowel/Colorectal CAM in a population survey carried out by TNS-British Market Research Bureau International (TNS-BMRB) in March 2010. RESULTS: STUDY 1: Internal reliability (Cronbach's alpha = 0.84) was high. Test-retest reliability was over r = 0.7 for warning signs, risk factors and age people are first invited for screening, but lower (between 0.6 and 0.7) for other items (lifetime risk, awareness of bowel cancer screening, age at risk). Bowel cancer experts achieved higher scores than equally educated controls (54.7 [4.3] vs. 42.9 [5.7]; P < 0.001) demonstrating the measure has construct validity and intervention participants showed higher knowledge than controls (51.4 [5.9] vs. 42.9 [5.7]; P < 0.001) suggesting the measure is sensitive to change. STUDY 2: Respondents recalled on average, one CRC sign and one risk factor. There was particularly low prompted awareness of the signs 'lump in the abdomen' (64%) and 'tiredness' (50%) and several lifestyle risk factors for CRC, e.g. exercise (37%). Respondents from more affluent groups had consistently higher knowledge of signs and risk factors compared to those from more deprived groups. CONCLUSIONS: The Bowel/Colorectal CAM meets accepted psychometric criteria for reliability and construct validity and should therefore provide a useful tool for assessment of CRC awareness. The population survey revealed low awareness of several CRC signs and risk factors and emphasises the importance of continuing public education, particularly about the link between lifestyle behaviours and CRC. BioMed Central 2011-08-23 /pmc/articles/PMC3188511/ /pubmed/21859500 http://dx.doi.org/10.1186/1471-2407-11-366 Text en Copyright ©2011 Power et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Power, Emily
Simon, Alice
Juszczyk, Dorota
Hiom, Sara
Wardle, Jane
Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK
title Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK
title_full Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK
title_fullStr Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK
title_full_unstemmed Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK
title_short Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK
title_sort assessing awareness of colorectal cancer symptoms: measure development and results from a population survey in the uk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188511/
https://www.ncbi.nlm.nih.gov/pubmed/21859500
http://dx.doi.org/10.1186/1471-2407-11-366
work_keys_str_mv AT poweremily assessingawarenessofcolorectalcancersymptomsmeasuredevelopmentandresultsfromapopulationsurveyintheuk
AT simonalice assessingawarenessofcolorectalcancersymptomsmeasuredevelopmentandresultsfromapopulationsurveyintheuk
AT juszczykdorota assessingawarenessofcolorectalcancersymptomsmeasuredevelopmentandresultsfromapopulationsurveyintheuk
AT hiomsara assessingawarenessofcolorectalcancersymptomsmeasuredevelopmentandresultsfromapopulationsurveyintheuk
AT wardlejane assessingawarenessofcolorectalcancersymptomsmeasuredevelopmentandresultsfromapopulationsurveyintheuk